Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Treatment of adolescents with major depression: contributions of a major trial.

Glass RM.

JAMA. 2004 Aug 18;292(7):861-3. No abstract available.

PMID:
15316001
2.

Adolescents with depression.

Carroll BJ.

JAMA. 2004 Dec 1;292(21):2578; author reply 2578-9. No abstract available.

PMID:
15572711
3.

Adolescents with depression.

Bridge JA, Brent DA.

JAMA. 2004 Dec 1;292(21):2578; author reply 2578-9. No abstract available.

PMID:
15572710
4.

Adolescents with depression.

Antonuccio D, Burns D.

JAMA. 2004 Dec 1;292(21):2577; author reply 2578-9. No abstract available.

PMID:
15572709
5.

Adolescents with depression.

Rifkin A, Rifkin W.

JAMA. 2004 Dec 1;292(21):2577-8; author reply 2578-9. No abstract available.

PMID:
15572708
6.

Treatment of adolescent depression: what we have come to know.

Vitiello B.

Depress Anxiety. 2009;26(5):393-5. doi: 10.1002/da.20572. Review. No abstract available.

PMID:
19404989
7.

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J; Treatment for Adolescents With Depression Study (TADS) Team.

JAMA. 2004 Aug 18;292(7):807-20.

PMID:
15315995
8.

A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.

Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.

Health Technol Assess. 2008 May;12(14):iii-iv, ix-60.

9.

[A place for SSRIs in the treatment of severely depressed children and adolescents].

Andeweg J, van Grinsven M.

Ned Tijdschr Geneeskd. 2008 Oct 25;152(43):2366; author reply 2366. Dutch. No abstract available.

PMID:
19024070
10.

Prescribing for depressed adolescents: office decision-making in the face of limited research evidence.

Gordon M, Melvin GA.

J Paediatr Child Health. 2014 Jul;50(7):498-503. doi: 10.1111/jpc.12517. Epub 2014 Mar 12. No abstract available.

PMID:
24617419
11.

The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial.

Davey CG, Chanen AM, Cotton SM, Hetrick SE, Kerr MJ, Berk M, Dean OM, Yuen K, Phelan M, Ratheesh A, Schäfer MR, Amminger GP, Parker AG, Piskulic D, Harrigan S, Mackinnon AJ, Harrison BJ, McGorry PD.

Trials. 2014 Nov 4;15:425. doi: 10.1186/1745-6215-15-425.

12.

Cost-effectiveness of depression treatment for adolescents.

Norquist G, McGuire TG, Essock SM.

Am J Psychiatry. 2008 May;165(5):549-52. doi: 10.1176/appi.ajp.2008.08020316. No abstract available.

PMID:
18450932
13.

Continuation cognitive-behavioural therapy maintains attributional style improvement in depressed patients responding acutely to fluoxetine.

Petersen T, Harley R, Papakostas GI, Montoya HD, Fava M, Alpert JE.

Psychol Med. 2004 Apr;34(3):555-61.

PMID:
15259840
14.

Fluoxetine in adolescents with major depression and an alcohol use disorder: an open-label trial.

Cornelius JR, Bukstein OG, Birmaher B, Salloum IM, Lynch K, Pollock NK, Gershon S, Clark D.

Addict Behav. 2001 Sep-Oct;26(5):735-9.

PMID:
11676382
15.

[A place for SSRIs in the treatment of severely depressed children and adolescents].

Roobol TH, Buitelaar JK.

Ned Tijdschr Geneeskd. 2008 Aug 2;152(31):1710-2. Dutch.

PMID:
18727599
16.

Benefits and harms of pediatric antidepressant medications.

Edwards JL, Kirk KK, Midha CK.

JAMA. 2007 Aug 8;298(6):626-7; author reply 627. No abstract available.

PMID:
17684183
17.

[Evidence for psychopharmacological treatment of depression in children and adolescents?].

Thomsen PH, Sørensen MJ.

Ugeskr Laeger. 2007 Apr 2;169(14):1289-94. Review. Danish.

PMID:
17437688
18.

Relative cost-effectiveness of treatments for adolescent depression: 36-week results from the TADS randomized trial.

Domino ME, Foster EM, Vitiello B, Kratochvil CJ, Burns BJ, Silva SG, Reinecke MA, March JS.

J Am Acad Child Adolesc Psychiatry. 2009 Jul;48(7):711-20. doi: 10.1097/CHI.0b013e3181a2b319.

PMID:
19465880
19.

The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.

March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J.

Arch Gen Psychiatry. 2007 Oct;64(10):1132-43. Erratum in: Arch Gen Psychiatry. 2008 Jan;65(1):101.

PMID:
17909125
20.

A depressed adolescent at high risk of suicidal behavior.

Vitiello B, Pearson JL.

Am J Psychiatry. 2008 Mar;165(3):323-8; quiz 408. doi: 10.1176/appi.ajp.2007.07101549. No abstract available.

PMID:
18316430

Supplemental Content

Support Center